China Branded Generics Market Assessment 2020-2026

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Branded Generics Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Value Added Branded Generics (Volume)
  • 2.1.2 Trade (Brand) Named Generics (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.2.1 Value Added Branded Generics (Value)
  • 2.2.2 Trade (Brand) Named Generics (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospital Pharmacies (Volume)
  • 3.1.2 Retail Pharmacies (Volume)
  • 3.1.3 Online Pharmacies (Volume)
  • 3.1.4 Drug Stores (Volume)
  • 3.1.5 Others (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Abbott Laboratories
  • 4.1.1 Abbott Laboratories Profiles
  • 4.1.2 Abbott Laboratories Product Information
  • 4.1.3 Abbott Laboratories Branded Generics Business Performance
  • 4.1.4 Abbott Laboratories Branded Generics Business Development and Market Status
• 4.2 Apotex
  • 4.2.1 Apotex Profiles
  • 4.2.2 Apotex Product Information
  • 4.2.3 Apotex Branded Generics Business Performance
  • 4.2.4 Apotex Branded Generics Business Development and Market Status
• 4.3 AstraZeneca
  • 4.3.1 AstraZeneca Profiles
  • 4.3.2 AstraZeneca Product Information
  • 4.3.3 AstraZeneca Branded Generics Business Performance
  • 4.3.4 AstraZeneca Branded Generics Business Development and Market Status
• 4.4 Dr.Reddy’s Laboratories
  • 4.4.1 Dr.Reddy’s Laboratories Profiles
  • 4.4.2 Dr.Reddy’s Laboratories Product Information
  • 4.4.3 Dr.Reddy’s Laboratories Branded Generics Business Performance
  • 4.4.4 Dr.Reddy’s Laboratories Branded Generics Business Development and Market Status
• 4.5 GlaxoSmithKline
  • 4.5.1 GlaxoSmithKline Profiles
  • 4.5.2 GlaxoSmithKline Product Information
  • 4.5.3 GlaxoSmithKline Branded Generics Business Performance
  • 4.5.4 GlaxoSmithKline Branded Generics Business Development and Market Status
• 4.6 Hospira
  • 4.6.1 Hospira Profiles
  • 4.6.2 Hospira Product Information
  • 4.6.3 Hospira Branded Generics Business Performance
  • 4.6.4 Hospira Branded Generics Business Development and Market Status
• 4.7 Lupin
  • 4.7.1 Lupin Profiles
  • 4.7.2 Lupin Product Information
  • 4.7.3 Lupin Branded Generics Business Performance
  • 4.7.4 Lupin Branded Generics Business Development and Market Status
• 4.8 Mylan N.V
  • 4.8.1 Mylan N.V Profiles
  • 4.8.2 Mylan N.V Product Information
  • 4.8.3 Mylan N.V Branded Generics Business Performance
  • 4.8.4 Mylan N.V Branded Generics Business Development and Market Status
• 4.9 Novartis AG
  • 4.9.1 Novartis AG Profiles
  • 4.9.2 Novartis AG Product Information
  • 4.9.3 Novartis AG Branded Generics Business Performance
  • 4.9.4 Novartis AG Branded Generics Business Development and Market Status
• 4.10 Par Pharmaceutical
  • 4.10.1 Par Pharmaceutical Profiles
  • 4.10.2 Par Pharmaceutical Product Information
  • 4.10.3 Par Pharmaceutical Branded Generics Business Performance
  • 4.10.4 Par Pharmaceutical Branded Generics Business Development and Market Status
• 4.11 Sandoz
• 4.12 Sanofi
• 4.13 Teva Pharmaceutical
• 4.14 Valeant
• 4.15 ZydusCadila
• 4.16 Others

5 Market Performance for Manufacturers

• 5.1 China Branded Generics Sales (K Units) and Market Share by Manufacturers 2014-2020
• 5.2 China Branded Generics Revenue (M USD) and Market Share by Manufacturers 2014-2020
• 5.3 China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
• 5.4 China Branded Generics Gross Margin of Manufacturers 2014-2020
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 South China Market Performance for Manufacturers
  • 6.1.1 South China Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.1.2 South China Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.1.3 South China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
  • 6.1.4 South China Branded Generics Gross Margin of Manufacturers 2014-2020
  • 6.1.5 Market Concentration
• 6.2 East China Market Performance for Manufacturers
  • 6.2.1 East China Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.2.2 East China Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.2.3 East China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
  • 6.2.4 East China Branded Generics Gross Margin of Manufacturers 2014-2020
  • 6.2.5 Market Concentration
• 6.3 Southwest China Market Performance for Manufacturers
  • 6.3.1 Southwest China Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.3.2 Southwest China Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.3.3 Southwest China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
  • 6.3.4 Southwest China Branded Generics Gross Margin of Manufacturers 2014-2020
  • 6.3.5 Market Concentration
• 6.4 Northeast China Market Performance for Manufacturers
  • 6.4.1 Northeast China Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.4.2 Northeast China Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.4.3 Northeast China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
  • 6.4.4 Northeast China Branded Generics Gross Margin of Manufacturers 2014-2020
  • 6.4.5 Market Concentration
• 6.5 North China Market Performance for Manufacturers
  • 6.5.1 North China Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.5.2 North China Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.5.3 North China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
  • 6.5.4 North China Branded Generics Gross Margin of Manufacturers 2014-2020
  • 6.5.5 Market Concentration
• 6.6 Central China Market Performance for Manufacturers
  • 6.6.1 Central China Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.6.2 Central China Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.6.3 Central China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
  • 6.6.4 Central China Branded Generics Gross Margin of Manufacturers 2014-2020
  • 6.6.5 Market Concentration
• 6.7 Northwest China Market Performance for Manufacturers
  • 6.7.1 Northwest China Branded Generics Sales (K Units) and Share of Manufacturers 2014-2020
  • 6.7.2 Northwest China Branded Generics Revenue (M USD) and Share of Manufacturers 2014-2020
  • 6.7.3 Northwest China Branded Generics Price (USD/Unit) of Manufacturers 2014-2020
  • 6.7.4 Northwest China Branded Generics Gross Margin of Manufacturers 2014-2020
  • 6.7.5 Market Concentration

7 China Branded Generics Market Performance (Sales Point)

• 7.1 China Branded Generics Sales (K Units) and Market Share by Regions 2014-2020
• 7.2 China Branded Generics Revenue (M USD) and Market Share by Regions 2014-2020
• 7.3 China Branded Generics Price (USD/Unit) by Regions 2014-2020
• 7.4 China Branded Generics Gross Margin by Regions 2014-2020

8 Development Trend for Regions (Sales Point)

• 8.1 China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.2 South China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.3 East China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.4 Southwest China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.5 Northeast China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.6 North China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.7 Central China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020
• 8.8 Northwest China Branded Generics Sales and Growth, Sales Value and Growth Rate2014-2020

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospital Pharmacies Industry
• 11.2 Retail Pharmacies Industry
• 11.3 Online Pharmacies Industry
• 11.4 Drug Stores Industry
• 11.5 Others Industry

12 Market Forecast 2021-2026

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
  • 12.1.1 China Branded Generics Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
  • 12.1.2 China Branded Generics Sales (K Units) and Growth Rate 2021-2026
  • 12.1.3 South China Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.4 East China Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.5 Southwest China Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.6 Northeast China Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.7 North China Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.8 Central China Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.9 Northwest China Branded Generics Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
  • 12.2.1 Overall Market Performance
  • 12.2.2 Value Added Branded Generics
  • 12.2.3 Trade (Brand) Named Generics
• 12.3 Sales and Growth Rate Forecast by Application 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Hospital Pharmacies
  • 12.3.3 Retail Pharmacies
  • 12.3.4 Online Pharmacies
  • 12.3.5 Drug Stores
  • 12.3.6 Others
• 12.4 Price (USD/Unit) and Gross Profit Forecast
  • 12.4.1 China Branded Generics Price (USD/Unit) Trend 2021-2026
  • 12.4.2 China Branded Generics Gross Profit Trend 2021-2026

13 Conclusion